Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3584]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic...
Dr Valentin Goede - University of Cologne, Cologne, Germany
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients ( Dr Valentin Goede - University of Cologne, Cologne, Germany )
8 May 2014
WIN Symposium 2014: Breakthrough biomarker investigations and combination...
Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg
WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies ( Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg )
6 May 2014
Work and history of the Kidney Cancer Association
Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer...
Work and history of the Kidney Cancer Association ( Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA )
6 May 2014
Intratumour heterogeneity in renal and lung cancer
Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK
Intratumour heterogeneity in renal and lung cancer ( Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK )
6 May 2014
Kidney cancer treatment ten years from now
Prof Martin Gore - The Royal Marsden Hospital, London, UK
Kidney cancer treatment ten years from now ( Prof Martin Gore - The Royal Marsden Hospital, London, UK )
6 May 2014
High levels of mutated p53 indicate metastatic phenotype
Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center...
High levels of mutated p53 indicate metastatic phenotype ( Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA )
5 May 2014
Personalisation of leukaemia treatment using genome sequencing
Dr Giovanni Martinelli - University of Bologna, Bologna, Italy
Personalisation of leukaemia treatment using genome sequencing ( Dr Giovanni Martinelli - University of Bologna, Bologna, Italy )
5 May 2014
History and ongoing work of AORTIC
Dr James Holland - Mount Sinai Hospital, New York, USA
History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )
5 May 2014
AORTIC and the benefits of coordination between different US NCI-designated...
Dr Lisa Stevens - National Cancer Institute, Bethesda, USA
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya ( Dr Lisa Stevens - National Cancer Institute, Bethesda, USA )
5 May 2014
Subset of breast cancer patients found to benefit from neratinib in latest trial
Dr John W. Park - University of California San Francisco, San Francisco, USA
Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )
1 May 2014
New antibody-drug conjugate shows early promise against all forms of melanoma
Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
1 May 2014
Phase II trial shows dacomitinib benefits a subgroup of patients with head and...
Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of...
Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer ( Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea )
1 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation